Zachary Stiles
Medical · Spokane, WANPI 1407374747
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,001 of the $7,215 with a category attached, or 69.3%. 47 manufacturers reported payments, led by Intuitive Surgical at 30.7% of the total. Among medical clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 274 payments — averaging $26.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Johnson & Johnson$492
- AbbVie$491
- AstraZeneca$446
- Boehringer Ingelheim$317
- Amgen$303
- plus $3K from 41 others
What the payments were for
- Travel & lodging$2143%
- Food & beverage$5,00169%
- Education$2,00028%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,214
- JARDIANCE$121
How this compares
$7,215 in reported general payments places this provider in the 95th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 140 | $262,595 |
| JardianceEmpagliflozin | 46 | $65,549 |
| XareltoRivaroxaban | 48 | $51,951 |
| EliquisApixaban | 27 | $31,847 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $25,633 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 13 | $25,254 |
| FarxigaDapagliflozin Propanediol | 18 | $25,036 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $19,284 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 510 | $18,227 |
| RexultiBrexpiprazole | 13 | $17,954 |
| Xtampza ErOxycodone Myristate | 26 | $14,493 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $14,480 |
| LinzessLinaclotide | 14 | $13,458 |
| SymbicortBudesonide/Formoterol Fumarate | 39 | $12,119 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $9,610 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $166 | $262,595140 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Stiolto Respimat | $317 | $100,41371 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $446 | $56,43979 claims |
| Johnson & JohnsonXarelto | $492 | $51,95148 claims |
| PfizerEliquis | $266 | $31,84727 claims |
| GSKTrelegy Ellipta | $201 | $25,63321 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $108 | $17,95413 claims |
| AbbVieLinzess, Synthroid | $491 | $14,76737 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $39 | $14,49326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 457 medical providers in Washington.
Other medical in Spokane
- Rebecca JohnsonSpokane$14K
- Julia TaylorSpokane$12K
- Kristine WesselsSpokane$10K
- Kyle RoblesSpokane$8K
- David BacaSpokane$8K
- Abigail KlemmeSpokane$7K
- Justin OverhoffSpokane$5K
- Alena IzhokhinaSpokane$4K
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.